Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Engert

Showing results (101-110 of 379) with videos related to

Pageof 38
Sort By:
Clinical Lymphoma & Myeloma|October 10, 2006
EXTEND PIX301: a phase III randomized trial of pixantrone versus other chemotherapeutic agents as third-line monotherapy in patients with relapsed, aggressive non-Hodgkin's lymphomaAndreas Engert, Rauol Herbrecht, Armando Santoro, et al.
Journal of Clinical Medicine|April 3, 2021
Hodgkin Lymphoma-Review on Pathogenesis, Diagnosis, Current and Future Treatment Approaches for Adult PatientsJesko Momotow, Sven Borchmann, Dennis A Eichenauer, et al.
Journal of the National Cancer Institute|July 18, 2014
Sixteenth biannual report of the Cochrane Haematological Malignancies Group: focus on Non-Hodgkin's lymphomaMichaela Rancea, Andrea Will, Peter Borchmann, et al.
Best Practice & Research. Clinical Haematology|March 29, 2005
Effectiveness of erythropoietin in the treatment of patients with malignancies: methods and preliminary results of a Cochrane reviewJulia F Bohlius, Simon Langensiepen, Andreas Engert, et al.
Haematologica|November 13, 2008
Pharmacokinetics of alemtuzumab in combination with fludarabine in patients with relapsed or refractory B-cell chronic lymphocytic leukemiaThomas Elter, Julia Kilp, Peter Borchmann, et al.
Journal of the National Cancer Institute|July 16, 2013
Fifteenth biannual report of the Cochrane Haematological Malignancies Group--focus on non-Hodgkin's lymphomaMichaela Rancea, Andrea Will, Peter Borchmann, et al.
The Cochrane Database of Systematic Reviews|July 23, 2008
Corticosteroids for preventing graft-versus-host disease after allogeneic myeloablative stem cell transplantationSusanne Quellmann, Guido Schwarzer, Kai Hübel, et al.
Case Reports in Oncology|April 9, 2011
Hodgkin's Lymphoma and Paraneoplastic Phenomena in the Central Nervous System: A Case Report and Review of the LiteratureMarcus Vetter, Alexandar Tzankov, Andreas Engert, et al.
Deutsches Arzteblatt International|February 2, 2013
The effect of specialized cancer treatment centers on treatment efficacy in Hodgkin's lymphomaBeate Klimm, Corinne Brillant, Nicole Skoetz, et al.
Journal of the National Cancer Institute|July 25, 2012
Fourteenth biannual report of the Cochrane Haematological Malignancies Group--focus on autologous stem cell transplantation in hematological malignanciesMichaela Rancea, Nicole Skoetz, Ina Monsef, et al.
Pageof 38

Showing results (101-110 of 379) with videos related to

Sort By:
Pageof 38
Clinical Lymphoma & Myeloma|October 10, 2006
EXTEND PIX301: a phase III randomized trial of pixantrone versus other chemotherapeutic agents as third-line monotherapy in patients with relapsed, aggressive non-Hodgkin's lymphomaAndreas Engert, Rauol Herbrecht, Armando Santoro, et al.
Journal of Clinical Medicine|April 3, 2021
Hodgkin Lymphoma-Review on Pathogenesis, Diagnosis, Current and Future Treatment Approaches for Adult PatientsJesko Momotow, Sven Borchmann, Dennis A Eichenauer, et al.
Journal of the National Cancer Institute|July 18, 2014
Sixteenth biannual report of the Cochrane Haematological Malignancies Group: focus on Non-Hodgkin's lymphomaMichaela Rancea, Andrea Will, Peter Borchmann, et al.
Best Practice & Research. Clinical Haematology|March 29, 2005
Effectiveness of erythropoietin in the treatment of patients with malignancies: methods and preliminary results of a Cochrane reviewJulia F Bohlius, Simon Langensiepen, Andreas Engert, et al.
Haematologica|November 13, 2008
Pharmacokinetics of alemtuzumab in combination with fludarabine in patients with relapsed or refractory B-cell chronic lymphocytic leukemiaThomas Elter, Julia Kilp, Peter Borchmann, et al.
Journal of the National Cancer Institute|July 16, 2013
Fifteenth biannual report of the Cochrane Haematological Malignancies Group--focus on non-Hodgkin's lymphomaMichaela Rancea, Andrea Will, Peter Borchmann, et al.
The Cochrane Database of Systematic Reviews|July 23, 2008
Corticosteroids for preventing graft-versus-host disease after allogeneic myeloablative stem cell transplantationSusanne Quellmann, Guido Schwarzer, Kai Hübel, et al.
Case Reports in Oncology|April 9, 2011
Hodgkin's Lymphoma and Paraneoplastic Phenomena in the Central Nervous System: A Case Report and Review of the LiteratureMarcus Vetter, Alexandar Tzankov, Andreas Engert, et al.
Deutsches Arzteblatt International|February 2, 2013
The effect of specialized cancer treatment centers on treatment efficacy in Hodgkin's lymphomaBeate Klimm, Corinne Brillant, Nicole Skoetz, et al.
Journal of the National Cancer Institute|July 25, 2012
Fourteenth biannual report of the Cochrane Haematological Malignancies Group--focus on autologous stem cell transplantation in hematological malignanciesMichaela Rancea, Nicole Skoetz, Ina Monsef, et al.
Pageof 38